Form 8-K - Current report:
SEC Accession No. 0001558370-21-009056
Filing Date
2021-07-21
Accepted
2021-07-21 17:06:06
Documents
13
Period of Report
2021-07-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cann-20210716x8k.htm   iXBRL 8-K 40973
2 EX-10.1 cann-20210716xex10d1.htm EX-10.1 193342
  Complete submission text file 0001558370-21-009056.txt   366353

Data Files

Seq Description Document Type Size
3 EX-101.SCH cann-20210716.xsd EX-101.SCH 3043
4 EX-101.LAB cann-20210716_lab.xml EX-101.LAB 13573
5 EX-101.PRE cann-20210716_pre.xml EX-101.PRE 8678
6 EXTRACTED XBRL INSTANCE DOCUMENT cann-20210716x8k_htm.xml XML 4123
Mailing Address 6565 EAST EVANS AVENUE DENVER CO 80224
Business Address 6565 EAST EVANS AVENUE DENVER CO 80224 303-759-1300
GENERAL CANNABIS CORP (Filer) CIK: 0001477009 (see all company filings)

EIN.: 208096131 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54457 | Film No.: 211105193
SIC: 2833 Medicinal Chemicals & Botanical Products